Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises BlackRock Renewable Finance (Dublin) Limited on its acquisition of Arise Wind Farm 10 AB
Mandate

Vinge advises BlackRock Renewable Finance (Dublin) Limited on its acquisition of Arise Wind Farm 10 AB

November 14, 2014

Vinge is advising BlackRock Renewable Finance (Dublin) Limited in connection with the acquisition of Arise Wind Farm 10 AB. The deal includes the sale of the construction-ready 46.2 MW Brotorp wind farm. Arise AB will manage the construction of the project, and once operational, operate the project on behalf of BlackRock Renewable Finance (Dublin) Limited through a construction and asset management agreement. BlackRock Renewable Finance (Dublin) Limited will provide equity to the project and a project finance facility has successfully been secured from SEB.

The Vinge team advising BlackRock Renewable Finance (Dublin) Limited includes partner Johan Göthberg and associates Gustav Jönsson and Johan Cederblad. Partner Fabian Ekeblad and associates Anders Morén and Oscar Rydén are advising on the financing of the transaction.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025